Tags

Type your tag names separated by a space and hit enter

breast cancer

breast cancer is a topic covered in the Taber's Medical Dictionary.

To view the entire topic, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

Nursing Central

-- The first section of this topic is shown below --

A malignant neoplasm (usually an adenocarcinoma) of the breast; the most common malignancy of American women and the leading cause of death in American women aged 40 to 55.

INCIDENCE
In 2011 the American Cancer Society estimated that 230,000 women would be newly diagnosed with invasive breast cancer, and that more than 39,000 women would die of the disease.

CAUSES
There are several known risk factors for breast cancer. SEE TABLE: Selected Risk Factors for Breast Cancer*

SYMPTOMS AND SIGNS
Breast cancer usually presents as a dominant mass in one breast, although the malignancy may first become evident when nipple discharge, nipple retraction, skin dimpling, or asymmetrical swelling of the breast occurs. In most cases breast cancers are first identified by women performing breast self-examination. A smaller but considerable number are detected by professional examination or mammography. About 1000 men are diagnosed with breast cancer annually. Breast cancer has several pathological variants. Carcinoma in situ, the most localized form of the disease, represents a preinvasive stage confined to a duct or lobule. Other presentations include lobular carcinoma, infiltrating ductal carcinoma, inflammatory carcinoma, and Paget disease of the nipple.

DIAGNOSIS
Regular breast self-examination, professional breast examination, and mammography are the keys to screening for breast cancer. All these screenings identify many more benign lesions than malignant ones, esp. in younger patients, and none of these techniques can definitively exclude breast cancer. Many mammographically detected lesions are benign, and about 15% of the time mammography will fail to detect lesions that are truly malignant. Digital mammography provides significantly better detection in women with dense breasts, those under age 50, and those who are premenopausal or perimenopausal. If a suspicious mass is identified, fine needle aspiration, core biopsy, or excisional biopsy must be used to obtain tissue for analysis. Ultrasonography can be used before biopsy to identify solid masses and cysts. Solid breast masses have a much greater chance of being malignant than cysts. Other imaging techniques used to help identify breast cancers include magnetic resonance imaging, positron emission tomography, and ductal imaging. SEE TABLE: Common and Experimental Techniques Used in Breast Imaging
SEE: breast self-examination; SEE: double reading; SEE: mammography

STAGING
The size of tumors and their possible metastasis to the chest wall, skin, axillae, or distant sites all determine the stage of breast cancer. Lymphatic mapping during cancer surgery can be used to find metastases to sentinel lymph nodes and guide therapies. Staging provides important information about the need for particular forms of therapy and the prognosis.


BREAST CANCER Possible paths of lymphatic spread

A biopsy (obtained by fine needle aspiration, with a stereotactic core needle, or by surgical lumpectomy) is usually recommended for any breast mass that does not resolve spontaneously within one or two menstrual cycles and for all postmenopausal women. Negative results from mammography and ultrasonography are not always accurate enough to rule out a malignant diagnosis.

TREATMENT
Combined modalities (including surgery, radiation, or drug therapies) are offered to many women with breast cancer, depending on their menopausal status and the stage of their disease at the time of diagnosis. Patients with stage I or II disease are offered either modified radical mastectomy (removal of the breast and 20 to 30 axillary lymph nodes) or lumpectomy with sentinel node or axillary dissection (as required) and radiotherapy, provided they have no contraindications to either of these choices. A variety of radiotherapy options are available, depending upon the individual patient's cancer. In premenopausal women with tumors larger than a centimeter, adjuvant chemotherapy prolongs survival, probably by eliminating microscopic metastases. Chemotherapeutic regimens commonly used include CMF (cyclophosphamide, methotrexate, and fluorouracil), CAF (cyclophosphamide, doxorubicin [Adriamycin], and fluorouracil), AC (doxorubicin [Adriamycin] and cyclophosphamide), doxorubicin (Adriamycin) followed by CMF, or FEC (fluorouracil, epirubicin, and cyclophosphamide). All of these agents are given several times in cycles of treatment. These same regimens are offered to vigorous postmenopausal women whose cancer has spread to axillary lymph nodes. Hormonal therapies like tamoxifen or raloxifene (two estrogen-receptor blockers) are also beneficial in patients with estrogen-receptor-positive tumors. Aromatase inhibitors (such as letrozole), and monoclonal antibodies (such as trastuzumab) may be prescribed for selected patients. After breast surgery, some women elect to have cosmetic restoration of the breast, either with saline- or silicone-filled implants or with tissue reconstructions made from the abdominal muscles. If breast cancer recurs after treatment, very high-dose chemotherapies are prescribed and peripheral stem cell transplantation is occasionally considered, but only in research settings. Bone metastases may be treated with monthly dosing of intravenous zoledronic acid (Zometa).
SEE: ductal carcinoma in situ of breast

PATIENT CARE
The patient's feelings and level of knowledge about her disease are determined. She is encouraged to express fears and concerns, and her family, supporters, or health care professionals stay with her during periods of anxiety or anguish. If surgery is planned, the procedure, postoperative care, and expected outcomes are explained.

While undergoing chemotherapy, the patient is monitored for adverse reactions (such as nausea, vomiting, anorexia, stomatitis, gastrointestinal ulceration, anemia, leukopenia, thrombocytopenia, and bleeding), so that they can be managed early. Weight and nutrition status are evaluated. The skin is inspected for redness, irritation, or breakdown if radiation therapy is prescribed, and aloe or a prescribed cream is applied. Bisphosphate drugs (such as alendronate or zolendronic acid) are administered to prevent or treat bone metastases or hypercalcemia, but their use may be associated with osteonecrosis of the jaw.

Comfort measures are used to promote relaxation and rest and to relieve anxiety. If immobility develops late in the disease, careful repositioning, excellent skin care, respiratory toilet, and low-pressure mattresses are used to prevent complications, e.g., skin breakdown, respiratory problems, and pathological fractures. The patient's and family's coping abilities are evaluated, and referral for counseling and support services may be necessary. End-stage disease patients benefit from hospice care. Women judged to be at high risk for breast cancer may have tamoxifen or ralozifene prescribed as preventative therapy.

Selected Risk Factors for Breast Cancer*
A personal history of breast cancer
Age (the risk increases with age)
Family history of breast cancer (in a mother, sister, daughter, or two or more close relatives such as cousins)
Age at first live birth (women who had their first child after age 30 and women who have never given birth are at higher risk)
Age at first menstrual period (women who had their first period before age 12 are at slightly higher risk)
Benign breast changes (atypical hyperplasia) or two or more breast biopsies even if no atypical cells were found
Race (white women are more likely to develop breast cancer than black women, but blacks are more likely than whites to die of it; Hispanic and Asian women have a lower risk of developing the disease)
Genetics: Several genes (including BRCA1 and BRCA2, among others) increase a woman's chance of developing breast cancer
Oral contraceptive pills and hormone replacement therapy may both slightly increase the risk of a woman's developing breast cancer
Obesity increases the risk of a woman's developing breast cancer
Alcohol use: The greater the alcohol intake of a woman, the greater the risk of breast cancer

Common and Experimental Techniques Used in Breast Imaging
Mammography: Computed tomographic laser mammography; digital mammography
Ductography
Elastography
Electrical impedance imaging (T-scan)
Magnetic resonance imaging (MRI)
Microwave imaging
Nuclear scanning
Optoacoustic tomography
Scintimammography (molecular breast imaging)
Thermography
Tomosynthesis
Ultrasonography


BREAST CANCER Infiltrating ductal carcinoma

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Venes, Donald, editor. "Breast Cancer." Taber's Medical Dictionary, 23rd ed., F.A. Davis Company, 2017. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/746466/all/breast_cancer.
Breast cancer. In: Venes D, ed. Taber's Medical Dictionary. 23rd ed. F.A. Davis Company; 2017. https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/746466/all/breast_cancer. Accessed May 24, 2019.
Breast cancer. (2017). In Venes, D. (Ed.), Taber's Medical Dictionary. Available from https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/746466/all/breast_cancer
Breast Cancer [Internet]. In: Venes D, editors. Taber's Medical Dictionary. F.A. Davis Company; 2017. [cited 2019 May 24]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/746466/all/breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - breast cancer ID - 746466 ED - Venes,Donald, BT - Taber's Medical Dictionary UR - https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/746466/all/breast_cancer PB - F.A. Davis Company ET - 23 DB - Nursing Central DP - Unbound Medicine ER -